Automated treatment planning of postmastectomy radiotherapy by Kisling, Kelly et al.
Automated treatment planning of postmastectomy radiotherapy
Kelly Kisling, and Lifei Zhang
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Simona F. Shaitelman
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
David Anderson and Tselane Thebe
Department of Radiation Oncology, University of Cape Town and Groote Schuur Hospital, Cape Town 8000, South Africa
Jinzhong Yang, Peter A. Balter, and Rebecca M. Howell
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Anuja Jhingran
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Kathleen Schmeler
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston,
Texas 77030, USA
Hannah Simonds
Division of Radiation Oncology, Stellenbosch University and Tygerberg Hospital, Cape Town 7505, South Africa
Monique du Toit and Christoph Trauernicht
Division of Medical Physics, Stellenbosch University and Tygerberg Hospital, Cape Town 7505, South Africa
Hester Burger, Kobus Botha, and Nanette Joubert
Division of Medical Physics, University of Cape Town and Groote Schuur Hospital, Cape Town 8000, South Africa
Beth M. Beadle
Department of Radiation Oncology, Stanford University, Stanford, CA 94305, USA
Laurence Courta)
Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA,
(Received 29 March 2019; revised 1 May 2019; accepted for publication 5 May 2019;
published 9 July 2019)
Purpose: Breast cancer is the most common cancer in women globally and radiation therapy is a
cornerstone of its treatment. However, there is an enormous shortage of radiotherapy staff, especially
in low- and middle-income countries. This shortage could be ameliorated through increased automa-
tion in the radiation treatment planning process, which may reduce the workload on radiotherapy staff
and improve efficiency in preparing radiotherapy treatments for patients. To this end, we sought to
create an automated treatment planning tool for postmastectomy radiotherapy (PMRT).
Methods: Algorithms to automate every step of PMRT planning were developed and integrated into
a commercial treatment planning system. The only required inputs for automated PMRT planning are
a planning computed tomography scan, a plan directive, and selection of the inferior border of the
tangential fields. With no other human input, the planning tool automatically creates a treatment plan
and presents it for review. The major automated steps are (a) segmentation of relevant structures (tar-
gets, normal tissues, and other planning structures), (b) setup of the beams (tangential fields matched
with a supraclavicular field), and (c) optimization of the dose distribution by using a mix of high-
and low-energy photon beams and field-in-field modulation for the tangential fields. This automated
PMRT planning tool was tested with ten computed tomography scans of patients with breast cancer
who had received irradiation of the left chest wall. These plans were assessed quantitatively using
their dose distributions and were reviewed by two physicians who rated them on a three-tiered scale:
use as is, minor changes, or major changes. The accuracy of the automated segmentation of the heart
and ipsilateral lung was also assessed. Finally, a plan quality verification tool was tested to alert the
user to any possible deviations in the quality of the automatically created treatment plans.
Results: The automatically created PMRT plans met the acceptable dose objectives, including target
coverage, maximum plan dose, and dose to organs at risk, for all but one patient for whom the heart
objectives were exceeded. Physicians accepted 50% of the treatment plans as is and required only
minor changes for the remaining 50%, which included the one patient whose plan had a high heart
dose. Furthermore, the automatically segmented contours of the heart and ipsilateral lung agreed well
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with manually edited contours. Finally, the automated plan quality verification tool detected 92% of
the changes requested by physicians in this review.
Conclusions: We developed a new tool for automatically planning PMRT for breast cancer, includ-
ing irradiation of the chest wall and ipsilateral lymph nodes (supraclavicular and level III axillary). In
this initial testing, we found that the plans created by this tool are clinically viable, and the tool can
alert the user to possible deviations in plan quality. The next step is to subject this tool to prospective
testing, in which automatically planned treatments will be compared with manually planned treat-
ments. © 2019 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of
American Association of Physicists in Medicine. [https://doi.org/10.1002/mp.13586]
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1. INTRODUCTION
Breast cancer is the most common cancer in women worldwide,
including many low- and middle-income countries (LMICs).1
Generally, breast cancer is diagnosed at more advanced stages
in LMICs compared with more developed countries.2 For breast
cancer with four or more positive lymph nodes, the standard of
care is postmastectomy radiotherapy (PMRT) to the chest wall
and ipsilateral lymph nodes, which reduces the risk of local
recurrence and improves survival.3–5 There are also increasing
indications to deliver PMRT to patients with one to three posi-
tive lymph nodes or those with high-risk node negative disease,
as radiation in such situations is associated with improvement
in disease-free survival.6 Planning PMRT treatments can be dif-
ficult and time-consuming, as it involves using a complex com-
bination of matched fields and various techniques to reduce the
dose to organs at risk (OARs) and improve the homogeneity of
dose to the targets. Planning such treatments is further compli-
cated by the lack of access to technologies that facilitate deep-
inspiration breath-hold techniques that reduce the dose to the
heart, which is often the case in resource-constrained clinics in
LMICs. These countries also have insufficient access to radio-
therapy7 in part because of a sizable shortage in the trained staff
needed to plan and deliver radiation treatment.8 Treatment plan-
ning constitutes a substantial amount of radiotherapy staff work-
load, and that workload could be reduced by increased
automation. Automation is also very useful in clinics with more
resources and should help to reduce healthcare costs.
To date, most work on automating treatment planning for
breast cancer has focused on a tangential field-only treatment
technique or on specific steps in treatment planning, such as
the inverse planning of tangential intensity-modulated radio-
therapy.9–13 Many of these techniques are effective and have
improved the efficiency of treatment planning. Expanding
from these efforts, we have developed a tool that automates
the entire planning process for PMRT, which is necessary for
treating more advanced breast cancers. The PMRT technique
differs from the previously automated tangential field-only
technique in that it includes a supraclavicular (SCV) field that
is matched to tangential fields via a non-divergent border at
the match line. Another unique feature of our current automa-
tion technique is that previous automation techniques require
a particular placement of external fiducial markers, which is
not standardized among clinics; the techniques and materials
used for placing these markers vary greatly. Our goal in the
present study was to develop an automated technique for
planning PMRT that can be widely used at multiple institu-
tions around the world. Thus, we designed a tool that does
not require the placement of external fiducial markers to
determine the borders of the treatment fields.
Herein we describe the automated treatment planning tool
we developed, including the techniques used for automation
and the results of a planning study for patients with breast
cancer who underwent PMRT. We developed this automated
planning tool in collaboration between institutions in the Uni-
ted States and South Africa, and it is intended for use in
resource-constrained settings for radiotherapy for locally
advanced breast cancer after mastectomy.
2. MATERIALS AND METHODS
2.A. Overview of the automated planning tool
The automated planning tool tested in this work designs
PMRT treatments using a monoisocentric tangential and
SCV field technique. To reduce the dose to OARs and
improve dose homogeneity in the targets, the algorithms in
this tool optimize the use of mixed high- and low-energy pho-
ton beams and, for the tangential fields, the use of field-in-
field (FIF) segments. The automated planning tool was devel-
oped assuming the radiation treatments would be planned on
a free-breathing computed tomography (CT) scans of patients
in the head-first, supine position owing to resource limita-
tions. The only external fiducial markers required are those
indicating the position of the marked isocenter (i.e., wires are
not necessary for determining the beam geometry). The exter-
nal fiducial markers indicating the marked isocenter are auto-
matically detected as described previously.14 The initial
version of this tool was developed for left-sided treatments
only. Given the additional complexity of left-sided treatments
because of the heart’s proximity to the targets in these treat-
ments, translating this approach to right-sided treatments
should be easier than translating it in the opposite direction.
Patient treatments were prescribed for a hypofractionated reg-
imen of 40.05 Gy delivered in 15 fractions.15
The techniques for PMRT planning automation used algo-
rithms developed in-house that were integrated with the
Eclipse treatment planning system (Varian Medical Systems,
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Palo Alto, CA, USA) via its application programming inter-
face. This PMRT planning tool is part of a suite of automated
planning tools called the Radiation Planning Assistant that is
being developed to automate planning processes for
resource-constrained clinics16 and currently includes treat-
ment planning for radiotherapy of cervical and head and neck
cancers.14,17 The inputs required by the Radiation Planning
Assistant are a plan directive from the physician specifying
the prescription and a CT scan for treatment planning.
Another input needed for automatically planning PMRT is
the location of the inferior border of the tangent. This addi-
tional user input is currently required because an automated
technique for identifying this border that is sufficiently reli-
able has yet to be found, largely because of substantial vari-
ability between patients. Therefore, the user is required to
identify the CT slice of the tangent fields’ inferior border
before automated planning is initiated.
The overall workflow for our automation technique for
PMRT is illustrated in Fig. 1. After automatic segmentation
of the targets, OARs, and additional planning structures, there
are two main automated planning steps: (a) setting up the
treatment beams and (b) optimizing the dose distributions.
These steps are described in detail below. Once automated
planning is completed, the user is presented with a composite
treatment plan consisting of the tangential and SCV field
plans, calculated dose, and heart and ipsilateral (left) lung
contours, all of which are created automatically. We also
implemented a technique to automatically verify the quality
of the treatment plan and determine when it deviates from
standard quality metrics to flag these deviations to the
reviewer of the plan.
2.A.1. Automation of segmentation
The first step in our planning process is to automatically
segment various anatomic structures, including the targets
(chest wall and lymph nodes), several OARs (e.g., both lungs,
heart, spinal canal), and other structures useful in defining
beam geometry (e.g., sternum, clavicle, trachea). Automated
segmentation was done using a tool developed by our group
and described in detail previously.18 In short, multiple atlases
of patient contours are deformed to the target patient and
combined by using fusion based on the simultaneous truth
and performance level estimation.19 These atlases were cre-
ated by our group and consisted of 11 patient CT scans with
contours. This multiatlas segmentation approach has been
successfully used for many other anatomic sites and has the
benefit of being easily adapted for different anatomical sites
by creating a new set of patient atlases with the desired con-
tours.17,20,21
2.A.2. Automation of beam setup
Once automatic segmentation was complete, the next step
was to determine the CT slice of the isocenter, representing
the match line between the tangential fields and the SCV
field. This slice was initially placed at the inferior aspect of
the clavicular head. From there, the posterior, non-divergent
border of the tangential fields (the principal border of the tan-
gents separating the chest wall from the OARs) was deter-
mined by using support vector machine classification. This
technique was adapted from the work described by Zhao
et al.12 and assigned points within the contours to one of two
classes: target (chest wall) and avoidance (heart, lungs, and
contralateral breast). These classified points were used as
inputs to the support vector machine to determine the optimal
three-dimensional plane separating the two classes for each
patient. This plane represents the posterior border of the tan-
gential fields and can be used to derive the beam parameters
for the medial and lateral tangential fields, including the gan-
try angles, collimator angles, and jaw/multileaf collimator
(MLC) positions defining the posterior border. The collimator
angle is set to zero, and the posterior border is defined using
the MLC. The anterior jaw is defined to provide 2 cm of flash
from the projection of the body contour. The inferior jaw is
defined at the projection of the slice of the body contour at
the inferior border (which was previously defined manually).
The first step in defining the SCV beam parameters after
automatic segmentation was to determine the optimal medial
border separating the targets (SCV lymph nodes) from the
FIG. 1. Overview of the method for automated planning of postmastectomy radiotherapy. OARs, organs at risk; BEV, beam's eye view; ROIs, regions of interest.
[Color figure can be viewed at wileyonlinelibrary.com]
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avoidance tissues (trachea and spinal canal). Again, a support
vector machine was used to find the optimal plane, and this
plane was used to define the gantry angle and medial jaw/
MLC positions of the SCV field. Finally, the superior jaw
was determined based on the beam’s eye view (BEV) projec-
tion of the cricoid cartilage, and the lateral jaw and MLC
positions for humeral head blocking were determined based
on the BEV projection of the humeral head.
In some cases, the location of the match line (and isocen-
ter in the superior–inferior direction) had to be automatically
adjusted based on the patient’s anatomy and beam geometry.
If the tangential field length exceeded the machine capabili-
ties (>20 cm for a Varian C-arm linear accelerator) or the part
of the SCV field inferior to the humeral head was insufficient
(<2 cm), the location of the match line was automatically
adjusted toward the inferior direction, and planning contin-
ued. In some cases with excessive lung exposure in the SCV
field (>4 cm based on the projection of the lung in the BEV),
the match line was moved more toward the superior direction.
In the latter case, two plans were created: the original plan
with the match line at the inferior aspect of the clavicular
head and an alternative plan with a more superior match line
to reduce the amount of lung in the SCV field. The rationale
for creating two plans was that several clinical factors con-
tributed to the decision to move the match line, including the
location of the level III axillary nodes and the possibility of
the tangential fields intersecting part of the patient’s arm. If
upon reviewing the original plan, the physician decides that
moving the match line in the superior direction is advanta-
geous, he or she can review the alternative match line plan.
The alternative match line plans were created while still con-
sidering the constraints of maximum tangential field length
and proximity of the match line to the humeral head. Figure 2
illustrates an example of the resulting SCV field BEV for the
original and alternative match line plans for one of the test
patients.
2.A.3. Automation of dose optimization
Once the parameters for the open beams were determined,
the three beams (medial and lateral tangents and SCV) were
automatically generated in the treatment planning system and
calculated for both 6- and 18-MV photons. Next, the dose per
beam was exported and used as inputs for optimizing the
dose distribution to reduce the maximum dose in the plan
and the doses to OARs while maintaining target coverage. A
normalization volume was created for each plan (tangential
and SCV). These normalization volumes were derived from
the automatic segmentations of the target structures (chest
wall for the tangential plan and SCV and level III axillary
lymph nodes for the SCV plan) that fell within the limits of
the treatment fields. The normalization volumes were used to
ensure that coverage was maintained throughout the opti-
mization such that 95% of the normalization volume received
95% of the prescribed dose.
In the optimization of the dose distribution, the relative
weights of the high- and low-energy beams were determined
first for the open fields by using a brute-force search strategy.
This optimization strategy allowed us to enforce the coverage
of the normalization volume while selecting combinations of
beam weights that met OAR dose constraints and minimized
the maximum dose. Next, for the tangential fields, FIF seg-
ments were created by positioning the MLCs to block the
projection of the hot dose cloud within each BEV, mimicking
a forward-planning methodology. The dose of the hot spot to
be blocked was determined adaptively based on the current
maximum dose in the optimization (usually less than the
maximum dose by 2%–6% of the prescription) and the rela-
tive size of the hot dose cloud in the BEV (to prevent exces-
sive blocking). The beam energy of each FIF segment and
relative weighting were also determined by using another
brute-force search. The process of creating FIF segments for
the tangents was repeated one time if the maximum dose in
the plan was greater than 110% of the prescription. The final
resulting plans could have at most two SCV fields (high- and
low-energy fields, no FIF segments) and four tangential field
segments per beam angle (high- and low-energy open fields,
two FIF segments). Combining the FIF segments with the
open fields would result in a maximum of six treatment
beams (two SCVs, two medial tangents, and two lateral tan-
gents).
2.B. Evaluation of automated treatment planning
The performance of the automated planning tool was
evaluated by using scans from a sample of ten patients
FIG. 2. Beam's eye view of supraclavicular fields for the original match line plan (left) and alternative match line plan (right) for the same patient. The contour of
the level III axillary nodes are shown projected in orange. [Color figure can be viewed at wileyonlinelibrary.com]
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who underwent left-sided mastectomy and a free-breathing
CT scan for radiotherapy planning at a partner hospital in
South Africa. These CT scans were acquired with the
patient in the head-first, supine position on a breast board
with both arms raised over the head. All patients had exter-
nal fiducial markers indicating their marked isocenters.
Some patients had additional wires placed for treatment
planning, although the wires were not used in this study.
The average separation of the chest wall for these patients
was 25.4 cm (range: 18.2–35.4 cm). These patients’ CT
scans were not used during algorithm development or pre-
liminary testing of the automatic planning tool. All patient
data used in this study were handled in accordance with an
approved institutional protocol.
2.B.1. Validation of automatic segmentation
Although our automated techniques for PMRT planning
make use of several automatically segmented structures for
creating treatment plans, only the heart and ipsilateral (left)
lung are presented with the plan. Therefore, the accuracy of
segmentation of these contours was validated by comparing
the automatically generated contours with physician-ap-
proved, manually edited contours. The physician-approved
contours were created by using our automatic segmentation
tool and then edited manually and reviewed and approved by
a radiation oncologist (S.F.S.) with expertise in treatment of
breast cancer. The contours were created according to the
guidelines provided in the Breast Cancer Atlas for Radiation
Therapy Planning from the Radiation Therapy Oncology
Group.22 The contours were compared geometrically by
using the Dice similarity coefficient, mean surface distance,
and Hausdorff distance and dosimetrically by using differ-
ences in dose metrics for each set of contours from the auto-
matically planned treatments.
2.B.2. Assessment of the automatically created
treatment plans
Once the automatically created plans were ready in the
treatment planning system, they were reviewed for acceptabil-
ity for treatment by two radiation oncologists with expertise
in the treatment of breast cancer (D.A. and T.T.) at Groote
Schuur Hospital (Cape Town, South Africa). The plans were
rated on a three-tiered scale: use plan as is, use plan with
minor changes, and plan requires major changes. The specific
changes requested for each plan were recorded. If a physician
requested to see the alternative match line plan for a patient,
that plan was shown to the physician (if it had been created),
and the physician selected the preferred plan. The physicians’
final plan ratings were reported for their selected preferred
plans.
The selected plans were also assessed quantitatively for
compliance with dose objectives for target coverage, OARs,
and maximum plan dose. These dose objectives were evalu-
ated by using the physician-approved, manually edited con-
tours. Coverage of the following target structures was
assessed: the chest wall, SCV lymph nodes, and level III axil-
lary lymph nodes. The preferred dose objectives and accept-
able dose limits used for the evaluation of the targets and
OARs are presented in Table I. These objectives were deter-
mined according to several sources, including recommenda-
tions from the Royal College of Radiologists,15 objectives
from the Alliance A221505 clinical trial of hypofractionated
PMRT (unpublished protocol),23 and clinical constraints
from collaborating institutions. Maximum doses were
assessed separately for tangential and SCV field plans (pre-
ferred maximum dose < 112% of the prescription) as well as
for the composite plan (preferred maximum dose < 116% of
the prescription).
2.C. Automated verification of PMRT plan quality
In the preliminary testing of the automated PMRT plan-
ning techniques, plans were most commonly rejected because
of their dosimetric properties rather than the geometric design
of the beam setup. As a result, automated verification of the
dose distribution was integrated into the automated PMRT
planning tool to alert the plan reviewer to these potential
dosimetric deviations, with alert thresholds set based on pub-
lished dose objectives or clinic-specific objectives. These
thresholds included maximum plan doses and doses to
OARs. Additional verifications included those of the amount
of lung projected in the BEV of the SCV and beam proper-
ties, such as the SCV gantry angle (Table II). The ability of
these verification tests to detect potential deviations in the
quality of the automatically planned treatments was evaluated
for the ten patient CT scans evaluated in this study.
TABLE I. Hypofractionated PMRT dose objectives for target coverage and
organs-at-risk.
Structure Dose metric Preferred objective Acceptable limit
Targets Volume > 95% Rx >95% n/a
Targets Volume > 90% Rx n/a >90%
Heart Mean dose <4 Gy <6 Gy
Volume > 25 Gy <7% <10%
Ipsilateral lung Volume > 17 Gy <35% <40%
PMRT, postmastectomy radiotherapy; Rx, prescription; n/a, not applicable.
TABLE II. Thresholds for automated verification tests of automated PMRT
plan quality.
Test object Test metric Threshold
Maximum dose (composite) Point dose >116% of prescription
Maximum dose (tangential plan) Point dose >112% of prescription
Maximum dose (SCV plan) Point dose >112% of prescription
Heart dose Mean dose <4 Gy
Volume > 25 Gy <7%
Ipsilateral lung dose Volume > 17 Gy <30%
Lung in SCV field Projection height <4 cm
SCVgantry angle Angle off vertical >15°
PMRT, postmastectomy radiotherapy; SCV, supraclavicular.
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3. RESULTS
3.A. Validation of automatic segmentation
The results of the geometric comparison of the auto-
matically generated and physician-approved contours of
the heart and ipsilateral lung are shown in Fig. 3. The
Dice similarity coefficient values were all at least 0.85 for
the heart and 0.93 for the ipsilateral lung, indicating very
good agreement. We also observed good agreement of the
mean surface distance, with all values less than 0.5 cm
for all contours. The greatest differences between the auto-
matically generated and physician-approved contours, as
indicated by the larger Hausdorff distances, occurred when
one contour included more slices in the superior or infe-
rior direction than the other.
The differences in the dose metrics when evaluated on the
physician-approved contours compared with the automati-
cally generated contours of the heart and ipsilateral lung are
also shown in Fig. 3. The differences were all small, resulting
in < 1 Gy difference in mean dose and less than a 2% differ-
ence in volume for the dose–volume histogram metrics.
Although the dose to the physician-approved contours did
trend higher than the automatically generated contours, it did
not affect whether a plan met the dose objectives for plan-
ning. This demonstrates that using the doses to the automati-
cally generated contours is appropriate when reporting plan
quality to the user. (Note: the doses reported in the sections
below are those to the manually edited contours.)
3.B. Assessment of the automatically created
treatment plans
On physician review of the final ten automatically planned
treatments, the physicians rated all plans either acceptable as
is (50%) or with only minor changes (50%). Of these plans,
four were the alternative plans, in which the physicians pre-
ferred that the match line be placed more superior to the orig-
inal match line. For the ten original plans, physicians
requested to see an alternative match line plan for five
patients. One of these patients was constrained by the tangen-
tial field length limit (>20 cm), so alternative plans were pre-
sented for the remaining four, all of which were preferred by
the physicians. Physicians requested a total of seven changes
for the five plans: adding a heart block to reduce the heart
dose in two patients, reducing the maximum dose in the tan-
gential plan for one patient with a large separation, and reduc-
ing the depth of nodal coverage to reduce the maximum dose
in the SCV plan, reducing the lung dose, adjusting the supe-
rior border of the SCV field, and adjusting the SCV angle in
one patient each.
The resulting dose metrics for the heart and ipsilateral
lung, coverage of the targets, and maximum doses are shown
FIG. 3. Comparison of the automatically generated and physician-approved contours of the heart and ipsilateral lung. The top row shows the following results of
the geometric comparisons: Dice similarity coefficient (DSC; left), mean surface distance (MSD; center), and Hausdorff distance (HD; right). The bottom row
shows the following results of the dosimetric comparisons: mean OAR dose (left) and dose–volume histogram metric (right). The absolute difference in metrics
was the results for the physician-approved contour minus that for the automatically generated contour for the same plan. [Color figure can be viewed at wileyon
linelibrary.com]
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in Fig. 4. Ninety percent of the plans met the acceptable
objective for the heart, with 60% meeting preferred objec-
tives, and all of the plans met the preferred objectives for the
ipsilateral lung. Regarding target coverage, all of the plans
met the preferred objective, in which 95% of the volume was
covered by 95% of the prescribed dose. Eighty percent of the
plans met the preferred objective for the maximum dose
(<116% of the prescribed dose). The two patients’ plans that
exceeded this value had maximum doses less than 118% of
the prescription dose that were caused by large chest wall sep-
aration and deep lymph node targets. The locations of the
maximum doses were checked to ensure that they did not fall
within the brachial plexus.
On average, we found that creation of one treatment plan
took 38 min (range 28–52 min). For plans for which an alter-
native match line plan was automatically created based on the
amount of lung in the SCV BEV, an average of 24 min
(range 17–28 min) was added to the planning time. On aver-
age, the majority of the time went toward setting up the
beams (19 min), contouring (11 min), and dose optimization
(7 min).
3.C. Automated verification of PMRT plan quality
In their evaluation of the ten treatment plans, physicians
requested a total of seven changes (described above) plus five
requests to review alternative match line plans. Of these 12
requests, 11 (92%) were detected by the automatic plan qual-
ity verification tests. The only requested change not detected
was adjustment of the SCV field’s superior border. The tests
detected four additional potential deviations that the physi-
cians did not request to be changed: two plans with slightly
high heart doses, one plan with a slightly high ipsilateral lung
dose, and one plan with a slightly large amount of lung in the
SCV field. All four of these potential deviations were very
close to the thresholds set for each test.
4. DISCUSSION
In this work, we demonstrated the clinical viability of our
automated planning tool for radiotherapy for locally advanced
breast cancer after mastectomy. We developed this tool with
the goal of reducing the workload on the limited radiotherapy
FIG. 4. The final dose metrics for the ten automatically planned treatments. The dose–volume histogram (DVH) metrics (top left), mean dose delivered to the
heart and ipsilateral lung (top right), coverage of targets by 95% or the prescription dose (bottom left), and maximum doses for the tangential and SCV plans and
for a composite of the two plans (bottom right) are shown. OARs, organs at risk; SCV, supraclavicular; Ax3, level III axillary; Rx, prescription. [Color figure can
be viewed at wileyonlinelibrary.com]
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staff of resource-constrained clinics, such as those in
LMICs.8 Such automated tools have the potential to reduce
staff workloads and improve the reliability of treatment plan-
ning.24 Investigators have shown that clinical implementation
of automated planning for tangential breast irradiation can
improve the efficiency and quality of treatment planning,
even facilitating same-day treatments.9,25 We would expect
an even greater gain in efficiency for automation of the com-
plex PMRT necessary for advanced breast cancers, which are
more common in LMICs owing to late-stage diagnosis. Some
have also suggested that reducing the effort spent in treatment
planning through automation could reduce the cost of radio-
therapy programs.26 Automation of PMRT planning is a
major step toward improving treatment planning efficiency,
especially given that breast cancer is one of the most common
cancers in LMICs.
To our knowledge, this is the first automated treatment
planning tool designed for PMRT, which uses tangential fields
to irradiate the chest wall matched with an oblique en face
beam to irradiate the SCV lymph nodes. Although some clin-
ics may also include the internal mammary chain (IMC)
lymph nodes in such treatment, this remains an area of contro-
versy.27 Treatment of the IMC increases the dose delivered to
the heart and the risk of heart disease.28 In the context of
patients undergoing free-breathing treatments because of
resource limitations in LMICs, the heart doses and risk of
heart disease are even higher. For this reason, clinics may only
treat the IMC if these nodes are suspected of being involved.
Therefore, we designed our automated planning tool for a
technique that irradiates the chest wall and SCV and level III
axillary lymph nodes, and not the IMC lymph nodes.
Without using external markers to set up the beams, the
automation algorithms determined the appropriate beam
angles for the tangential fields in this test cohort. However,
not using markers means that one manual input is required
for treatment planning: the location of the inferior border of
the tangential fields. In the user interface of our automated
planning tool, this border is conveniently selected in the same
workspace in which the CT scan is approved for automated
planning, which should add negligible effort and time to the
entire planning process. Also, clinicians may follow their typ-
ical process for marking the inferior border, such as place-
ment of a wire, to facilitate their selection of this location.
The patient CT scans we tested here as well as those used pre-
viously in the development of this automated planning tool
came from several different institutions. As a result, a variety
of approaches for placing markers and wires were used for
these patients, which did not seem to influence the perfor-
mance of our algorithms in setting up the beams.
We also integrated a method into our automated planning
tool to automatically alert reviewers of the PMRT plan to any
potential discrepancies in plan quality, which mainly resulted
from the plan’s dose distribution. Given the proximity of the
targets to sensitive normal tissues and the variations in patient
anatomy, balancing normal tissue sparing and full target cov-
erage is sometimes a challenge in radiotherapy for breast can-
cer. We designed our automated treatment planning tool to
create plans with full coverage of the target volumes. There-
fore, this automatic verification may be useful in alerting the
plan reviewer to potential discrepancies in plan quality, such
as high heart dose, which may call for adjustment of the plan
depending on the acceptable clinical compromises for that
particular patient and plan. The alerts generated by the auto-
matic plan quality verification tests could help expedite
adjustment of treatment plans if necessary and improve the
safety of automated treatment planning by automatically
alerting the plan reviewer to potential issues with the plan.
The current version of this automated planning tool for
PMRT designs radiation treatments based on specific clinical
practices that may vary by institution, including patient posi-
tioning (supine, both arms up), the use of free-breathing scans,
the location of the match line or superior border of the SCV
field, and a hypofractionated treatment regimen. However, the
automation techniques presented herein can be easily adapted
to comply with variations in this clinical practice. Some varia-
tions in practice may require greater adaptations in the
automation technique, but are still feasible. One example is
the use of a single-energy photon beam, which is common in
many clinics, rather than a mix of high- and low-energy
beams. With adaptation, automation of PMRT with a single-
energy photon beam is very likely possible, although the dose
distributions for many patients would be expected to be hotter
than those with mixed-energy photon beams. Another possi-
ble adaptation is using tangential and SCV fields for the treat-
ment of intact breast and at-risk nodes. By changing the
automatic segmentation to create the breast contour to use as
the target for the tangents rather than the chest wall, the
automation techniques would function the same as those used
for planning PMRT. Before clinical implementation, all of
these adaptations would need to be tested thoroughly.
In the evaluation described herein, we retrospectively
planned PMRT treatments for a small cohort of patients with
locally advanced breast cancer after mastectomy that required
only minor changes or were acceptable for treatment as is. We
also found that the automatic segmentation of the heart and
ipsilateral lung was sufficiently accurate for presentation to
the end user. A limitation of this work was the small number of
patient datasets available for testing, which was a result of the limi-
tations of data sharing agreements among the collaborating institu-
tions. During the development of the algorithms presented here,
wewere able to test earlier versions of the automated planning tool
on 29 patient CT scans. We then used ten previously untested CT
scans for testing the final version (presented here). Moving for-
ward, we will subject this automated planning tool to prospective
testing with our collaborating institutions before clinical imple-
mentation. In this prospective testing, we will compare automati-
cally generated PMRT plans head-to-head with the corresponding
manually created treatment plans.
The automated planning tool tested in this study was not
optimized for time, and for some patients took as long as
52 min to create a plan. However, this is time that does not
have to be spent by staff actively creating a treatment plan.
After this study was completed and in preparation for clinical
implementation, the tool was deployed on a network of servers
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that utilize parallel processes, a distributed calculation frame-
work, and further improvements in computational speed.
Based on preliminary data from testing this system, we esti-
mate that the time to create a plan will be reduced to be less
than 20 min for all patients.
Key considerations for clinical deployment of this auto-
mated treatment planning tool are ensuring that patient selec-
tion and setup are appropriate for the treatment technique
planned by this automated tool. Thorough training will be
necessary to ensure safe use and help users understand the
specifications of this system. During clinical implementation,
we will collect data on planning times to quantify improve-
ments in efficiency when using this automated planning tool.
5. CONCLUSIONS
We developed and tested an automated planning tool for
PMRT and demonstrated its viability for implementation in
resource-constrained clinics in LMICs. This tool has the
potential to improve efficiency in planning these complex
treatments for breast cancer.
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